Business Development Executive Pharma Partnerships

About Us

Founded in 2011 Fulgent has evolved into a premier full-service genomic testing company built around a foundational technology platform.

Through our diverse testing menu Fulgent is focused on transforming patient care in oncology anatomic pathology infectious and rare diseases and reproductive health. We believe that by providing a wide range of effective flexible testing options in conjunction with best-in-class service and support we can redefine the way medicine is managed for patients and clinicians alike.

Since integrating with our therapeutic development business Fulgent is also developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform. By merging our fields of expertise we aim to become a fully integrated precision medicine company.

Summary of Position

Fulgent Genetics is seeking a scientifically fluent and commercially driven Business Development Executive Pharma Partnerships to join our Pharma Services division.

This is a field-based client-facing role focused on building new partnerships with pharmaceutical and biotechnology companies engaged in translational research biomarker discovery and clinical development.

The ideal candidate has 35 years of experience in business development or scientific sales within a CRO pharma services or molecular testing environment and thrives on identifying opportunities engaging scientific teams and driving adoption of Fulgents multi-omics and molecular testing solutions.

The role is designed for a hunter someone who combines scientific understanding with relationship-building skills and enjoys being in the field connecting with researchers and decision-makers across the pharma-biotech ecosystem in the assigned territory.

Key Job Elements

Field Prospecting & Client Outreach

• Prospect evaluate and negotiate new business opportunities across the biopharma sector.
• Identify and engage with new pharmaceutical and biotech organizations.
• Build relationships with scientists translational research leads and biomarker program managers.
• Conduct in-person meetings networking and event attendance to expand visibility and uncover opportunities.

Consultative Engagement

• Lead scientific and operational discussions to understand client goals and design tailored service solutions.
• Collaborate with internal scientific and technical teams to prepare proposals and ensure alignment with project objectives.
• Present Fulgents capabilities in genomics proteomics and other molecular testing platforms clearly and persuasively.

Pipeline Development & Territory Management

• Maintain a qualified pipeline of new opportunities through consistent outreach and follow-up.
• Document interactions and progress in CRM (Salesforce).
• Provide accurate forecasts and territory updates to leadership.
• Demonstrate creative approach for increasing brand awareness through in-field engagement.

Cross-Functional Collaboration

• Partner with Project Management Laboratory Operations and Marketing to ensure a smooth transition from initial contact to project launch.
• Share competitive and market insights to inform business strategy.

Success Indicators

• Consistent generation of new pharma and biotech relationships leading to qualified opportunities.
• Strong field presence and reputation within the biotech community.
• Effective collaboration with internal teams to deliver timely high-quality client solutions.
• Measurable contribution to new project wins and territory revenue growth.

Knowledge/Experience

• Masters degree or higher in Molecular Biology Biochemistry Genetics or related field strongly preferred; Bachelors with relevant laboratory or industry experience will be considered.
• 35 years of experience in business development or account management within pharma biotech or CRO molecular testing services.
• Demonstrated success initiating and developing new client relationships in translational or biomarker programs.
• Solid understanding of molecular and multi-omics workflows (e.g. genomics proteomics spatial biology).
• Excellent communication and presentation skills with the ability to engage both scientific and business audiences.
• Highly organized self-motivated and comfortable working independently in the field.
• Willingness to travel (3040%) for client visits conferences and networking events.

Reports To

• Senior Business Development Manager or Director of Biopharma Technical Services

Environment

Fulgent Therapeutics LLC is an Equal Employment Opportunity Employer.

The work environment characteristics described here are representative of those an employee encounters while performing the essential functions of this job. Reasonable accommodation may be made to enable qualified individuals with disabilities to perform the essential functions. The term qualified individual with a disability means an individual with a disability who with or without reasonable accommodation can perform the essential functions of the position.

Safety and Work Environment:

• General office environment when not in the field. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.
• Maintains a clean neat and orderly work area.
• Adheres to Department-Specific Safety Guidelines.

Physical Demands:

• Standing sitting walking bending reaching manual manipulation and lifting up to 10 pounds.
• Must pass a color vision test if responsibilities require color discrimination.

For California residents please see the link below to access our CCPA Privacy Notice.

CCPA Privacy Notice for California Residents

note that Fulgent (and its affiliated companies including Inform Diagnostics and CSI Laboratories) does not accept unsolicited information and/or resumes from search firms or agencies for our job postings. Search firms or agencies without an applicable contract and/or express approval to recruit for the role in question that choose to submit a resume or client information to our career page or to any employee of Fulgent will not be eligible for payment of any fee(s) and any associated shared data will become the property of Fulgent.